Member update: February 2019
Garg named endowed chairNeil Garg
Founded in 2017, the chair was established in part by a gift from the estate of the late UCLA professor Ken Trueblood and his wife, Jeanie Trueblood.
After joining the UCLA faculty in 2007, Garg was promoted to associate professor in 2012 and full professor in 2013. He served as vice chair for the department of chemistry and biochemistry from 2012 through 2016. His research focuses on developing novel methods for synthesizing organic molecules.
Outside the classroom, Garg has developed several educational tools, including an app called “Backside Attack” that teaches organic chemistry and “The Organic Coloring Book,” which he self-published, to introduce children to organic chemistry concepts.
Moore honored for mentoringKathryn J. Moore
Kathryn J. Moore has received the 2018 Mentor of Women Award from the American Heart Association.
Sponsored by the AHA’s Council on Arteriosclerosis, Thrombosis and Vascular Biology, the award is presented to a member of the council who has demonstrated excellence in supporting the careers of women in those three fields.
Moore is a professor of cardiology and cell biology at the New York University School of Medicine. At her lab, her research focuses on understanding the innate immune system and microRNAs in the regulation of lipoprotein metabolism and atherosclerosis.
Since 2014, Moore has served as an associate editor for the Journal of Lipid Research.
The award was presented at the Vascular Discovery: From Genes to Medicine Scientific Sessions 2018 conference, held in May.
HUPO council members elected
Five members of the American Society for Biochemistry and Molecular Biology are among the newest members elected to the Human Proteome Organization council. They are:
- Michelle Hill of the Berghofer Medical Research Institute, Queensland, Australia
- Robert Moritz of the Institute for Systems Biology, Seattle (HUPO vice president, re-elected to the council)
- Olga Vitek of Northeastern University, Boston
- Lennart Martens of the University of Ghent-VIB, Belgium
- Anne-Claude Gingras of the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada
Founded in 2001, HUPO is an international scientific organization that promotes proteomics by aiding in the development of new technologies and techniques to understand human disease better.
The HUPO Council consists of up to 48 scientists who represent the three global regions, Asia/Oceania, Europe/Africa, and North/South America.
The new members’ council terms last three years, from January 2019 through December 2021.
Bennett receives breakthrough prizeC. Frank Bennett
Bennett shares the prize for developing Spinraza, an effective antisense oligonucleotide therapy for children with spinal muscular atrophy.
Bennett and the other recipients were honored at the Breakthrough Prize ceremony, known as the “Oscars of Science,” in November.
Founded in 2013 and sponsored by Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng, Yuri and Julia Milner, and Anne Wojcicki, the Breakthrough Prizes recognize achievement in life sciences, fundamental physics and mathematics.
The 2019 recipients shared a total of $22 million for their discoveries.
Liu named department chairXiaoqi Liu
Xiaoqi Liu has been named chair of the department of toxicology and cancer biology at the University of Kentucky.
Liu is a biochemist who seeks to develop new cancer therapies by exploring the molecular mechanisms that cause cancer. His research focuses on the enzyme Pololike kinase 1, which plays a central role in many types of cancer.
Liu’s lab will be moving into the university’s new $265 million research building, which opened in 2018.
Liu was previously a professor of biochemistry at Purdue University. He also served as the leader of the Cell Identity and Signaling Program, a research group at Purdue focusing on basic cancer research.
In memoriam: John VournakisJohn Vournakis
The American Society for Biochemistry and Molecular Biology recently learned that biochemist and biotech executive John Nicholas Vournakis passed away Jan. 17, 2018. He was 78.
Vournakis was born Dec. 1, 1939, in Cambridge, Ohio, to Nicholas John and Pota Vournakis. He received his B.S. at Albion College in 1961 and his Ph.D. in physical biochemistry in 1968 from Cornell University.
After obtaining his Ph.D, he was a research fellow first at the Massachusetts Institute of Technology and later at Harvard.
His first tenured position was in 1973 at Syracuse University, where he served on the faculty for 12 years as a professor of biology. He later joined Dartmouth College as a professor in 1985.
Vournakis also was involved in several biotechnology companies. He was vice president for startup companies Verax and Genmap. He additionally co-founded Marine Polymer Technologies and Admune Therapeutics, which developed therapeutic drugs to treat cancer.
He is survived by his wife, Karen, and his son, Christopher.
Join the ASBMB Today mailing list
Sign up to get updates on articles, interviews and events.
For small-molecule cancer drugs, context is everything. Drugs that ameliorate cancer in some tissues may increase the cancer risk in others. Researcher Stephen Safe has turned this challenge into an opportunity.